Table 3.
antigen | NY-ESO-1 | p | |||
− | + | Σ | (2-sided) | ||
perineural invasion | − | 8 | 10 | 18 | 0.464 |
+ | 23 | 19 | 42 | ||
Σ | 31 | 29 | 60 | ||
resection margins | − | 18 | 19 | 37 | 0.483 |
+ | 15 | 22 | 37 | ||
Σ | 33 | 41 | 74 | ||
nodal status | − | 16 | 9 | 25 | 0.307 |
+ | 4 | 5 | 9 | ||
Σ | 20 | 14 | 34 | ||
primary site | MSG* | 21 | 17 | 38 | 0.037 |
OTH† | 15 | 31 | 46 | ||
Σ | 36 | 48 | 84 | ||
site of failure | LR‡ | 9 | 13 | 22 | 0.595 |
DIS§ | 8 | 16 | 24 | ||
Σ | 17 | 29 | 46 | ||
histologic growth pattern | non solid | 30 | 37 | 67 | 0.486 |
solid | 6 | 11 | 17 | ||
Σ | 36 | 48 | 84 | ||
antigen | Pan-MAGE | p | |||
− | + | Σ | (2-sided) | ||
perineural invasion | − | 12 | 6 | 18 | 0.859 |
+ | 27 | 15 | 42 | ||
Σ | 39 | 21 | 60 | ||
resection margins | − | 27 | 10 | 37 | 0.144 |
+ | 21 | 16 | 37 | ||
Σ | 48 | 26 | 74 | ||
nodal status | − | 20 | 5 | 25 | 0.045 |
+ | 4 | 5 | 9 | ||
Σ | 24 | 10 | 34 | ||
primary site | MSG* | 28 | 10 | 38 | 0.215 |
OTH† | 28 | 18 | 46 | ||
Σ | 26 | 28 | 84 | ||
site of failure | LR‡ | 14 | 8 | 22 | 0.936 |
DIS§ | 15 | 9 | 24 | ||
Σ | 29 | 17 | 46 | ||
histologic growth pattern | non solid | 45 | 22 | 67 | 0.850 |
solid | 11 | 6 | 17 | ||
Σ | 56 | 28 | 84 |
= major salivary glands
= other
= local and/or regional failure
= distant failure
Σ=sum, −=negative, +=positive.